BioCentury
ARTICLE | Clinical News

Marina Biotech, Mirna preclinical data

March 3, 2014 8:00 AM UTC

In vitro, mir-34 mimics plus Tarceva erlotinib inhibited proliferation of erlotinib-resistant NSCLC and HCC cells. Data were published in PLoS ONE. Mirna's MRX34 - a synthetic mimic of miR-34, a natu...